In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Clinical use of antimicrobial body washes questioned at CTFA/SDA symposium on HCCM.

This article was originally published in The Rose Sheet

Executive Summary

BODY WASH ANTIMICROBIALS CLINICAL USEFULNESS QUESTIONED BY FDA Division of Anti-infective Drug Products Clinical Reviewer David Bostwick at a June 2-3 symposium on the Healthcare Continuum Model held jointly by the Cosmetic, Toiletry and Fragrance Association and the Soap and Detergent Association. The model, which was submitted to FDA in June 1995, is the industry's answer to regulation of antimicrobial products used by consumers, food handlers and healthcare professionals ("The Rose Sheet" April 3, 1995, p. 1). The proposal responds to the agency's 1994 TFM which set up a regulatory scheme for antimicrobial skin cleanser categories ("The Tan Sheet" June 27, 1994, pp. 7-10).



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts